SunOpta director receives 3,332-share equity grant
KEATING LESLIE STARR reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
KEATING LESLIE STARR reported acquisition or exercise transactions in this Form 4 filing.
SunOpta Inc. director Leslie Starr Keating received a grant of 3,332 Common Shares on April 17, 2026 at an indicated value of $6.47 per share. The shares were issued in lieu of cash for service on the board of directors, reflecting stock-based compensation rather than an open-market purchase. Following this award, Keating directly holds 148,311 Common Shares of SunOpta, indicating the transaction is a modest, routine adjustment to an existing equity position.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Shares | 3,332 | $6.47 | $22K |
Footnotes (1)
- F1. The shares were issued in lieu of cash to the reporting person for service on the board of directors.
Key Figures
Key Terms
Form 4 regulatory
Grant, award, or other acquisition financial
board of directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SunOpta (STKL) report for Leslie Starr Keating?
Was Leslie Starr Keating’s SunOpta (STKL) transaction an open-market buy or compensation grant?
What does the Form 4 code 'A' mean in SunOpta (STKL) director Keating’s filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.